Skip to main content
Top
Published in: Journal of Cancer Survivorship 2/2014

01-06-2014

Oncology providers’ evaluation of the use of an automatically generated cancer survivorship care plan: longitudinal results from the ROGY Care trial

Authors: Kim A. H. Nicolaije, Nicole P. M. Ezendam, M. Caroline Vos, Johanna M. A. Pijnenborg, Lonneke V. van de Poll-Franse, Roy F. P. M. Kruitwagen

Published in: Journal of Cancer Survivorship | Issue 2/2014

Login to get access

Abstract

Purpose

Previous studies have merely investigated oncology providers’ a priori attitudes toward SCPs. The purpose of the current study was to longitudinally evaluate oncology providers’ expectations and actual experiences with the use of an automatically generated Survivorship Care Plan (SCP) in daily clinical practice.

Methods

Between April 2011 and October 2012, the participating oncology providers (i.e., gynecologists, gynecologic oncologists, oncology nurses) provided usual care or SCP care to 222 endometrial and 85 ovarian cancer patients included in the Registrationsystem Oncological GYnecology (ROGY) Care trial. All (n = 43) oncology providers in both arms were requested to complete a questionnaire before and after patient inclusion regarding their expectations and evaluation of SCP care.

Results

Before patient inclusion, 38 (88 %; 21 SCP, 17 usual care), and after patient inclusion, 35 (83 %; 20 SCP, 15 usual care) oncology providers returned the questionnaire. After patient inclusion, oncology providers were generally satisfied with the SCP (M = 7.1, SD = 1.3, with 1 = not at all–10 = very much) and motivated to keep using the SCP (M = 7.9, SD = 1.5). Most providers (64 %) encountered barriers. Twenty-five percent felt they used more time for consultations (M = 7.3 min, SD = 4.6). However, self-reported consultation time did not differ between before (M = 21.8 min, SD = 11.6) and after patient inclusion (M = 18.7, SD = 10.6; p = 0.22) or between SCP care (M = 18.5, SD = 10.3) and usual care (M = 22.0, SD = 12.2; p = 0.21).

Conclusions

Oncology providers using the SCP were generally satisfied and motivated to keep using the SCP. However, the findings of the current study suggest that even when the SCP can be generated automatically, oncology providers still have difficulties with finding the time to discuss the SCP with their patients.

Implications for Cancer Survivors

If SCP care is indeed effective, overcoming the perceived barriers is needed before large-scale implementation in order for cancer survivors to fully benefit from the potential advantages of SCPs.
Appendix
Available only for authorised users
Literature
1.
go back to reference Erikson C, Salsberg E, Forte G, Bruinooge S, Goldstein M. Future supply and demand for oncologists: challenges to assuring access to oncology services. J Oncol Pract. 2007;3:79–86.PubMedCentralCrossRefPubMed Erikson C, Salsberg E, Forte G, Bruinooge S, Goldstein M. Future supply and demand for oncologists: challenges to assuring access to oncology services. J Oncol Pract. 2007;3:79–86.PubMedCentralCrossRefPubMed
3.
go back to reference Hewitt M, Greenfield S, Stovall E. From cancer patient to cancer survivor: lost in transition. Washington, DC: National Academies Press; 2006. Hewitt M, Greenfield S, Stovall E. From cancer patient to cancer survivor: lost in transition. Washington, DC: National Academies Press; 2006.
5.
go back to reference Baravelli C, Krishnasamy M, Pezaro C, Schofield P, Lotfi-Jam K, Rogers M, et al. The views of bowel cancer survivors and health care professionals regarding survivorship care plans and post treatment follow up. J Cancer Surviv. 2009;3:99–108.CrossRefPubMed Baravelli C, Krishnasamy M, Pezaro C, Schofield P, Lotfi-Jam K, Rogers M, et al. The views of bowel cancer survivors and health care professionals regarding survivorship care plans and post treatment follow up. J Cancer Surviv. 2009;3:99–108.CrossRefPubMed
6.
go back to reference Hewitt ME, Bamundo A, Day R, Harvey C. Perspectives on post-treatment cancer care: qualitative research with survivors, nurses, and physicians. J Clin Oncol. 2007;25:2270–3.CrossRefPubMed Hewitt ME, Bamundo A, Day R, Harvey C. Perspectives on post-treatment cancer care: qualitative research with survivors, nurses, and physicians. J Clin Oncol. 2007;25:2270–3.CrossRefPubMed
7.
go back to reference Watson EK, Sugden EM, Rose PW. Views of primary care physicians and oncologists on cancer follow-up initiatives in primary care: an online survey. J Cancer Surviv. 2010;4:159–66.CrossRefPubMed Watson EK, Sugden EM, Rose PW. Views of primary care physicians and oncologists on cancer follow-up initiatives in primary care: an online survey. J Cancer Surviv. 2010;4:159–66.CrossRefPubMed
8.
go back to reference Kantsiper M, McDonald EL, Geller G, Shockney L, Snyder C, Wolff AC. Transitioning to breast cancer survivorship: perspectives of patients, cancer specialists, and primary care providers. J Gen Intern Med. 2009;24:S459–66.CrossRefPubMed Kantsiper M, McDonald EL, Geller G, Shockney L, Snyder C, Wolff AC. Transitioning to breast cancer survivorship: perspectives of patients, cancer specialists, and primary care providers. J Gen Intern Med. 2009;24:S459–66.CrossRefPubMed
9.
go back to reference Brennan ME, Butow P, Spillane J, Boyle FM. Survivorship care after breast cancer: follow-up practices of Australian health professionals and attitudes to a survivorship care plan. Asia Pac J Clin Onc. 2010;6:116–25.CrossRef Brennan ME, Butow P, Spillane J, Boyle FM. Survivorship care after breast cancer: follow-up practices of Australian health professionals and attitudes to a survivorship care plan. Asia Pac J Clin Onc. 2010;6:116–25.CrossRef
11.
go back to reference Campbell MK, Tessaro I, Gellin M, Valle CG, Golden S, Kaye L, et al. Adult cancer survivorship care: experiences from the LIVESTRONG centers of excellence network. J Cancer Surviv. 2011;5:271–82.PubMedCentralCrossRefPubMed Campbell MK, Tessaro I, Gellin M, Valle CG, Golden S, Kaye L, et al. Adult cancer survivorship care: experiences from the LIVESTRONG centers of excellence network. J Cancer Surviv. 2011;5:271–82.PubMedCentralCrossRefPubMed
12.
go back to reference Ganz PA. Quality of care and cancer survivorship: the challenge of implementing the institute of medicine recommendations. J Oncol Pract. 2009;5:101–5.PubMedCentralCrossRefPubMed Ganz PA. Quality of care and cancer survivorship: the challenge of implementing the institute of medicine recommendations. J Oncol Pract. 2009;5:101–5.PubMedCentralCrossRefPubMed
13.
go back to reference Stricker CT, Jacobs LA, Risendal B, Jones A, Panzer S, Ganz PA, et al. Survivorship care planning after the institute of medicine recommendations: how are we faring? J Cancer Surviv. 2011;5:358–70.CrossRefPubMed Stricker CT, Jacobs LA, Risendal B, Jones A, Panzer S, Ganz PA, et al. Survivorship care planning after the institute of medicine recommendations: how are we faring? J Cancer Surviv. 2011;5:358–70.CrossRefPubMed
14.
go back to reference Faul LA, Rivers B, Shibata D, Townsend I, Carbrera P, Quin GP, et al. Survivorship care planning in colorectal cancer: feedback from survivors and providers. J Psychosoc Oncol. 2012;30:198–216.PubMedCentralCrossRefPubMed Faul LA, Rivers B, Shibata D, Townsend I, Carbrera P, Quin GP, et al. Survivorship care planning in colorectal cancer: feedback from survivors and providers. J Psychosoc Oncol. 2012;30:198–216.PubMedCentralCrossRefPubMed
15.
go back to reference Horning SJ. Follow-up of adult cancer survivors: new paradigms for survivorship care planning. Hematol Oncol Clin North Am. 2008;22:201–10.CrossRefPubMed Horning SJ. Follow-up of adult cancer survivors: new paradigms for survivorship care planning. Hematol Oncol Clin North Am. 2008;22:201–10.CrossRefPubMed
16.
go back to reference Earle CC. Long term care planning for cancer survivors: a health services research agenda. J Cancer Surviv. 2007;1:64–74.CrossRefPubMed Earle CC. Long term care planning for cancer survivors: a health services research agenda. J Cancer Surviv. 2007;1:64–74.CrossRefPubMed
17.
18.
go back to reference Hill-Kayser CE, Vachani C, Hampshire MK, Jacob LA, Metz JM. An internet tool for creation of cancer survivorship care plans for survivors and health care providers: design, implementation, use, and user satisfaction. J Med Internet Res. 2009;11:e39.PubMedCentralCrossRefPubMed Hill-Kayser CE, Vachani C, Hampshire MK, Jacob LA, Metz JM. An internet tool for creation of cancer survivorship care plans for survivors and health care providers: design, implementation, use, and user satisfaction. J Med Internet Res. 2009;11:e39.PubMedCentralCrossRefPubMed
19.
go back to reference van de Poll-Franse LV, Nicolaije KAH, Vos MC, Pijnenborg JM, Boll D, Husson O, et al. The impact of a cancer Survivorship Care Plan on gynecological cancer patient and health care provider reported outcomes (ROGY Care): study protocol for a pragmatic cluster randomized controlled trial. Trials. 2011;12:256.PubMedCentralCrossRefPubMed van de Poll-Franse LV, Nicolaije KAH, Vos MC, Pijnenborg JM, Boll D, Husson O, et al. The impact of a cancer Survivorship Care Plan on gynecological cancer patient and health care provider reported outcomes (ROGY Care): study protocol for a pragmatic cluster randomized controlled trial. Trials. 2011;12:256.PubMedCentralCrossRefPubMed
20.
go back to reference Ganz PA, Hahn EE. Implementing a survivorship care plan for patients with breast cancer. J Clin Oncol. 2008;26:759–67.CrossRefPubMed Ganz PA, Hahn EE. Implementing a survivorship care plan for patients with breast cancer. J Clin Oncol. 2008;26:759–67.CrossRefPubMed
21.
go back to reference Tuinman MA, Gazendam-Donofrio SM, Hoekstra-Weebers JEHM. Screening and referral for psychosocial distress in oncologic practice: use of the Distress Thermometer. Cancer. 2008;113:870–8.CrossRefPubMed Tuinman MA, Gazendam-Donofrio SM, Hoekstra-Weebers JEHM. Screening and referral for psychosocial distress in oncologic practice: use of the Distress Thermometer. Cancer. 2008;113:870–8.CrossRefPubMed
22.
go back to reference Earle CC. Failing to plan is planning to fail: improving the quality of care with survivorship care plans. J Clin Oncol. 2006;24:5112–6.CrossRefPubMed Earle CC. Failing to plan is planning to fail: improving the quality of care with survivorship care plans. J Clin Oncol. 2006;24:5112–6.CrossRefPubMed
24.
go back to reference Stricker CT, Jacobs LA, Palmer SC. Survivorship care plans: an argument for evidence over common sense. J Clin Oncol. 2012;30:1392–3.CrossRefPubMed Stricker CT, Jacobs LA, Palmer SC. Survivorship care plans: an argument for evidence over common sense. J Clin Oncol. 2012;30:1392–3.CrossRefPubMed
25.
go back to reference Grunfeld E, Julian A, Pond G, Maunsell E, Coyle D, Folkes A, et al. Evaluating survivorship care plans: results of a randomized, clinical trial of patients with breast cancer. J Clin Oncol. 2011;29:4755–62.CrossRefPubMed Grunfeld E, Julian A, Pond G, Maunsell E, Coyle D, Folkes A, et al. Evaluating survivorship care plans: results of a randomized, clinical trial of patients with breast cancer. J Clin Oncol. 2011;29:4755–62.CrossRefPubMed
26.
go back to reference Brothers BM, Easley A, Salani R, Andersen BL. Do survivorship care plans impact patients’ evaluations of care? A randomized evaluation with gynecologic oncology patients. Gynecol Oncol. 2013;129:554–8.PubMedCentralCrossRefPubMed Brothers BM, Easley A, Salani R, Andersen BL. Do survivorship care plans impact patients’ evaluations of care? A randomized evaluation with gynecologic oncology patients. Gynecol Oncol. 2013;129:554–8.PubMedCentralCrossRefPubMed
Metadata
Title
Oncology providers’ evaluation of the use of an automatically generated cancer survivorship care plan: longitudinal results from the ROGY Care trial
Authors
Kim A. H. Nicolaije
Nicole P. M. Ezendam
M. Caroline Vos
Johanna M. A. Pijnenborg
Lonneke V. van de Poll-Franse
Roy F. P. M. Kruitwagen
Publication date
01-06-2014
Publisher
Springer US
Published in
Journal of Cancer Survivorship / Issue 2/2014
Print ISSN: 1932-2259
Electronic ISSN: 1932-2267
DOI
https://doi.org/10.1007/s11764-013-0327-1

Other articles of this Issue 2/2014

Journal of Cancer Survivorship 2/2014 Go to the issue
Webinar | 19-02-2024 | 17:30 (CET)

Keynote webinar | Spotlight on antibody–drug conjugates in cancer

Antibody–drug conjugates (ADCs) are novel agents that have shown promise across multiple tumor types. Explore the current landscape of ADCs in breast and lung cancer with our experts, and gain insights into the mechanism of action, key clinical trials data, existing challenges, and future directions.

Dr. Véronique Diéras
Prof. Fabrice Barlesi
Developed by: Springer Medicine